These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: MicroRNA-146a protects against LPS-induced organ damage by inhibiting Notch1 in macrophage.
    Author: Bai X, Zhang J, Cao M, Han S, Liu Y, Wang K, Han F, Li X, Jia Y, Wang X, Shi J, Hu D.
    Journal: Int Immunopharmacol; 2018 Oct; 63():220-226. PubMed ID: 30103197.
    Abstract:
    MicroRNA-146a is a well-studied microRNA participating in immune and inflammatory diseases, but its role in sepsis has not been investigated. Here in our study, we found increased level of microRNA-146a in macrophage stimulated by lipopolysaccharide. In addition, the mRNA level of Notch1 was also increased. Up-regulation of microRNA-146a by miR-146a-mimic alleviated inflammatory responses of macrophage, for the levels of IL-1β, IL-6 and CCL-2 were decreased, and the activation of NF-κB signaling was inhibited. The histological examination showed that microRNA-146a protected against organ damage in mice with lipopolysaccharide injection, and the level of inflammatory factors, Cr, BUN, AST and ALT in serum were all decreased, reflecting the alleviated inflammation and recovered organ function. Then predicting databases were used and Notch1 was predicted as one of the potential targets of microRNA-146a. Knockout of Notch1 in macrophage showed reduced secretion of inflammatory factors and attenuated activation of NF-κB signaling in response to lipopolysaccharide. Specifically knockout of Notch1 in macrophage protected mice from LPS induced organ damage and dysfunction. Therefore, we prove that miR-146a acts as an inhibitor of inflammation by targeting Notch1 in macrophage, therefore protects mice from organ damage in sepsis.
    [Abstract] [Full Text] [Related] [New Search]